Cargando…
Residual cardiovascular risk in individuals on lipid-lowering treatment: quantifying absolute and relative risk in the community
OBJECTIVE: The residual cardiovascular disease (CVD) risk in individuals on long-term lipid-lowering treatment (LLT) in the general population is not well described. METHODS: We estimated absolute CVD risks by age and sex for different categories of low-density lipoprotein cholesterol (LDL-C) levels...
Autores principales: | Lieb, Wolfgang, Enserro, Danielle M, Larson, Martin G, Vasan, Ramachandran S |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BMJ Publishing Group
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5786911/ https://www.ncbi.nlm.nih.gov/pubmed/29387429 http://dx.doi.org/10.1136/openhrt-2017-000722 |
Ejemplares similares
-
Systematic review of clinical guidelines for lipid lowering in the secondary prevention of cardiovascular disease events
por: Brown, Rosemary Elisabeth, et al.
Publicado: (2020) -
Systematic screening for cardiovascular risk at pharmacies
por: Rohla, Miklos, et al.
Publicado: (2016) -
Estimated 10-year cardiovascular mortality seriously underestimates overall cardiovascular risk
por: Jørstad, Harald T, et al.
Publicado: (2016) -
Cardiovascular risk after hospitalisation for unexplained syncope and orthostatic hypotension
por: Yasa, Ekrem, et al.
Publicado: (2018) -
Ergothioneine is associated with reduced mortality and decreased risk of cardiovascular disease
por: Smith, Einar, et al.
Publicado: (2020)